← FDA Drug Approvals (Drugs@FDA)

PORTRAZZA

BLA · Biologics License Application · Sponsor: ELI LILLY CO · Approved 2015-11-24

Drug application

FDA Application #
BLA125547
Application type
Biologics License Application
Brand name
PORTRAZZA
Generic name
NECITUMUMAB
Active ingredients
NECITUMUMAB
Dosage form
INJECTABLE
Route
INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL
Marketing status
Prescription
Sponsor
ELI LILLY CO
Manufacturer
Eli Lilly and Company
First approval
2015-11-24

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown